Stock Ratings / Industrials / BHST / financials

RML (58) STKE (50) CHWM (59) SGLD (52) ⌘ Pro Terminal →

BioHarvest Sciences Inc. (BHST) Revenue-to-Profit Sankey Flow & SEC XBRL Financials

$1.66 -5.68% NASDAQ • Live Quote vs Prior Daily Close (Synced Snapshot) EXT / AFTER-HRS: $1.64

BioHarvest Sciences Inc. (BHST) carries a Roarable Rating of E (Strong Sell) with 34/100 RQD Confidence due to weak cash-flow efficiency and sensitivity to current interest rates. Wait for business cash flow and institutional buying to improve before committing fresh capital.

📊 Historical Track Record Warning: Scores below 50 (34/100 · E) historically underperformed SPY in 71% of rolling 90-day windows →

ROARABLE E • RED ALERT Cap $37.6M

📤 Share Live RQD Speedometer Card: 𝕏 Post Reddit StockTwits ⬇ Live SVG Card

INTERACTIVE SCENARIO DECK:

🛡️ Portfolio Crash X-Ray

EXT / AFTER-HRS: $1.64 (-1.21%)🧬 Disciplined Float (+0.72% YoY Shares)⚙️ Cash Engine: 6/20 (E) • 0% FCF Margin

Verify 90D Bucket Audit →

📊 Historical Track Record Warning: Scores below 50 (34/100 · E) historically underperformed SPY in 71% of rolling 90-day windows (-8.7% avg 90D alpha vs SPY • 29.0% hit rate).

Audit Bucket Track Record →

RQD QUANT TACHOMETERRED ALERT • E

2-of-3 JEV AI Jury Bearish Warning

Cash

SEC

Whale

Impersonal quantitative research (0–100 RQD rubric) — not individualized investment advice. Past performance does not guarantee future results. Full Disclaimer

5-PILLAR SNOWFLAKE RADARRw E · Rk D

Each axis scored 0–20

12M PRICE TARGET CONE-10.8% Base Target

WHALE OPTIONS SNAPSHOT: — (No Active Options Snapshot on file for BHST)Realized 20D OHLCV Swing Band: ±12.5%

Deterministic 5-Pillar Attribution (34/100 Composite)

🔍 WHY BHST SCORES 34/100 (E) — TOP 3 DRIVERS2 Bullish Pillars + #1 Risk Drag

▲ #1 Bullish Driver: SEC 10-K Forensic Risk+11/20 pts (32% of score)

Altman Z-Score 3.80 (FORTRESS SAFE (>3.0)) • Piotroski F-Score 5/9

▲ #2 Bullish Driver: Macro Regime Fit+8/20 pts (24% of score)

FRED Regime × Technicals: 4% of 52W Range • RSI-14 at 48 (NEUTRAL RANGE)

▼ #1 Drag / Risk Factor: Whale & Options Positioning4/20 pts (-16 pt drag)

Put hedging (50% put share) caps near-term gamma upside (-16 pts vs max)

📈 PAST 4 QUARTERS RQD vs SUBSEQUENT RETURNQ1 → Q2 → Q3 → Current

Q1 (-3Q)

Grade E$1.66+11.4% Next Q

Q2 (-2Q)

Grade E$1.85-7% Next Q

Q3 (-1Q)

Grade E$1.72-3.5% Next Q

Current

Grade E$1.66-8.7% Hist 90D α

Trajectory: E (26) → E (34)Full Audit →

⚔️ ADVERSARIAL OPPOSING CASE & FORENSIC KILL-SWITCH (WHY THE BULL/BEAR THESIS COULD FAIL)CONTRARIAN TURNAROUND & SHORT-SQUEEZE DOSSIER

⚔️ Adversarial Opposing Case: What Could Spark a BHST Turnaround Squeeze

Gideon Ashmere Forensic Desk →

While BHST currently carries a cautious 34/100 (E) rating due to Whale & Options Positioning (4/20), shorts face asymmetric squeeze risk if free cash flow inflects or management executes accretive buybacks.

🚀 Contrarian Squeeze Trigger #1

Established market leader in Industrials with deep daily trading liquidity.

🚀 Contrarian Squeeze Trigger #2

Options & Short-Covering Gamma: Reclaiming the 50-day SMA ($1.70) and Max Pain ($1.74) forces dealer call-delta covering toward $9.74.

🚀 Contrarian Squeeze Trigger #3

Forensic Repair Trigger: Halting share dilution (Disciplined Float (+0.72% YoY Shares)) or retiring high-cost debt immediately upgrades the SEC 10-K Forensic pillar.

🎲 LIVE PREDICTION MARKET ODDS TIED TO $BHST• $2.4M Crowd Pool • Kalshi / Polymarket Composite

Contract: “BHST Beats Next Quarter EPS Consensus (Dec 30, 2026) & Holds Above 200D SMA”

YES 34%NO 66%Trade / Inspect Odds →

VISUAL REVENUE-TO-PROFIT SANKEY WATERFALL • FY 2025 (10-K)

How BHST Turns Every Dollar of Sales Into Real Bottom-Line Profit

Free Cash Flow:$0 (0% FCF Margin)

Multi-Year SEC EDGAR XBRL Revenue, Net Profit & Free Cash Flow Trajectory

■ Revenue■ Net Profit■ Free Cash Flow

FY23

Rev $12.7M

FY24

Rev $25.2M

FY25

Rev $34.5M

Fiscal Year	Revenue	Gross Margin	Op Margin	Net Profit	Free Cash Flow	ROIC %
FY 2025	$34.5M	59.3%	-16.2%	-$11.1M	-$9.6M	-45%
FY 2024	$25.2M	55.4%	-27.7%	-$12.9M	-$9.5M	-45%
FY 2023	$12.7M	59.3%	-78.6%	-$12.6M	-$8.5M	-35%

ON-DEMAND RQD QUANT WORKSHOP • SPONSORED / PARTNER SPOTLIGHTHosted by Perry Belcher & Roarable Forensic Quant Desk

Red-Light Warning Desk: Spotting SEC Cash-Flow & Dilution Risks Before Downgrades (Featuring BHST)

✓Walkthrough of BHST's RQD Radar, SEC cash-conversion gap & downside invalidation levels
✓3 asymmetric Bear/Hedge frameworks when 10-year Treasury yields stay elevated
✓Includes nightly RQD rating-change & forensic signal email alerts on your tracked stocks

RQD INSIDER CLUB WAITLIST$49/YR PLANNED

Want Custom AI PineScript / Python Indicators & Priority Rating-Change Alerts?

Join Founding VIP Waitlist (No Card Required) →$100K Arena

BHST // CANDLESTICK & AUTO-TRENDLINE WORKSTATION6M: -60.57%▲ RESISTANCE BREAKOUT

2026-10-30O $1.66H $1.67L $1.64C $1.66VOL 2.5K

RES: $1.65SUP: $1.22SMA50: $1.70SMA200: $3.24

PRIMARY-SOURCE FORENSICS, SECOND-ORDER LINKS & AI ANALYST DESK

BHST Dilution Monitor, Expectations Hurdle, Butterfly Connections & Policy Exposure

🦋 BHST Butterfly Map → + Track BHST →

Share Count & Dilution Monitor (#25)

Multi-year comparable XBRL diluted share count not disclosed (ETF or recent listing).

Reverse-DCF Expectations Hurdle (#30)

8.0%/yr Implied 5Y Growth

vs. +37.0% actual YoY revenue growth (assuming 9.25% cost of equity & 16.5x terminal multiple).

Ellis Vennor Setup Ledger (#33)

No active Ellis Vennor swing setup published on BHST today. View full Setup Ledger →

🦋 Documented & Second-Order Butterfly Connections Open Graph →

No direct multi-tier Butterfly edges indexed yet for BHST. Explore sector supply chains on /butterfly.

AI Analyst Theses, Washington Policy & Company Video

🎬 No recent verified company-specific video clip queued for BHST today (we never pad ticker pages with unrelated generic clips). Browse Macro Video Desk →

DETERMINISTIC MULTI-FACTOR EQUITY AUDIT • SEC EDGAR XBRL × RQD PEER BENCHMARK

📊 Quantitative Sector Peer Comparison, SEC Filing Delta & Investment FAQ (BHST)

Industrials Rank #420 of 485 ⚔️ RML vs BHST Full Matrix →

1. Head-to-Head Industrials Peer Comparison (BHST vs. RML, STKE, CHWM, SGLD)

Industry: Diversified Equities (43 Tracked Issuers)

Across 485 tracked Industrials securities in the Roarable RQD universe, BioHarvest Sciences Inc. (BHST) ranks #420 by composite RQD confidence (34/100, grade E) and #418 by equity capitalization ($37.6M). Within this direct 5-issuer industry benchmark cohort, BHST leads on earnings valuation at N/A trailing P/E, while BHST leads on capital efficiency and profitability with -35.0% ROIC and 59.3% gross margin. CHWM currently holds the highest overall quantitative score in the immediate peer group at 59/100 (C-) compared with BHST at 34/100 (E).

Ticker / Company	Roarable Grade	RQD Score	Trailing P/E	Gross Margin	ROIC	1D Change	Market Cap	Head-to-Head
BHST ACTIVE BioHarvest Sciences Inc.	E	34/100	—	59.3%	-35.0%	-5.68%	$37.6M	Benchmark Subject
RML Resolution Minerals Ltd	D+	58/100	—	—	—	-1.99%	$44.1M	/rml-vs-bhst →
STKE Sol Strategies Inc.	D	50/100	—	—	—	-1.16%	$50.5M	/stke-vs-bhst →
CHWM Chilwa Minerals Limited American Depository Shares	C-	59/100	—	—	—	+9.34%	$59.6M	/chwm-vs-bhst →
SGLD Scorpio Gold Corporation	D+	52/100	—	—	—	+0.58%	$60.1M	/sgld-vs-bhst →

2. Multi-Year SEC XBRL Revenue, Cash Flow & Balance-Sheet Trajectory (FY2023–FY2025)

SEC EDGAR 10-K • FILED 2025-12-31 • CIK 0001723464

In its most recent audited fiscal period (FY2025, filed 2025-12-31), BioHarvest Sciences Inc. (BHST) reported GAAP revenue of $34.5M (+37.0% vs. FY2024 revenue of $25.2M , and +172.3% cumulative change since FY2023) , GAAP net income of -$11.1M, operating cash flow of -$7.2M, and free cash flow of -$9.6M (-0.7% YoY). On the balance sheet, BHST closed FY2025 with $0 in total assets against $0 in total debt (Altman Z-Score: N/A, Piotroski F-Score: 5/9).

Fiscal Period	Filing Date	Revenue	Net Income	Operating Cash Flow	Free Cash Flow	Total Assets	Total Debt
FY2025 (FY)	2025-12-31	$34.5M	-$11.1M	-$7.2M	-$9.6M	—	—
FY2024 (FY)	2024-12-31	$25.2M	-$12.9M	-$6.7M	-$9.5M	—	—
FY2023 (FY)	2023-12-31	$12.7M	-$12.6M	-$8.5M	-$8.5M	—	—

3. BHST Data-Verified Investor FAQ (RQD Rating, Sector Peers, SEC Forensics & Technicals)

✓ SCHEMA.ORG FAQPAGE JSON-LD ENABLED

Is BHST stock a Buy, Hold, or Sell right now according to Roarable's RQD model?

As of 2026-11-01, BioHarvest Sciences Inc. (NASDAQ: BHST) is rated E (Strong Sell / SELL) by Roarable's 5-pillar RQD engine with a composite confidence score of 34/100 at a spot price of $1.66 (-5.68% 1D, market cap $37.6M). Pillar breakdown: Fundamental Cash Engine 6/20, Institutional 13F & Options Flow 4/20, Executive Insider Alignment 11/20, FRED Macro Regime Fit 8/20, and SEC Balance-Sheet Forensics 5/20. Across 485 tracked Industrials issuers, BHST ranks #420 in composite RQD confidence.

How does BHST compare to RML and STKE in the Industrials sector?

Within the Industrials sector (Diversified Equities), BHST carries a Roarable E (34/100 RQD), trailing P/E of N/A, gross margin of 59.3%, and ROIC of -35.0%. By comparison, RML (Resolution Minerals Ltd) holds a D+ grade (58/100 RQD, P/E N/A, ROIC —, cap $44.1M) and STKE (Sol Strategies Inc.) posts a D grade (50/100 RQD, P/E N/A, ROIC —, cap $50.5M). Among the 5-stock peer group, BHST leads on earnings multiple (N/A) while BHST leads on capital efficiency (-35.0% ROIC).

What are the biggest fundamental strengths and SEC risk factors for BHST?

Per BHST's SEC EDGAR XBRL 10-K filing (FY2025, filed 2025-12-31, CIK 0001723464), BioHarvest Sciences Inc. generated $34.5M in revenue (+37.0% YoY), -$11.1M in net income, and -$9.6M in free cash flow against $0 in total assets and $0 in total debt. Key quantitative strengths: Established market leader in Industrials with deep daily trading liquidity.. Primary risk factors monitored: Company executives have done more routine share selling than personal cash buying lately.. Institutional options positioning shows a 50% call / 50% put premium split.

Where is BHST trading relative to its 50-day, 200-day, and 52-week technical levels?

BHST last traded at $1.66 (-5.68% on volume of 20,428 shares), positioning the stock -2.35% below its 50-day simple moving average ($1.70) and -48.77% below its 200-day simple moving average ($3.24). Across its 52-week range of $1.37 to $9.28, BHST sits at the 3.7% percentile with a 14-day RSI of 48.0 (NEUTRAL RANGE) and an implied next-earnings move of ±12.5% ($1.45 to $1.87).

BHST Investor FAQ & Complete 8-Part Research Index

100% OPEN ACCESS • SEC EDGAR × CBOE × FRED

How profitable is BioHarvest Sciences Inc. (BHST)?

In FY 2025 (10-K), BHST converted $34.5M of revenue into a 59.3% gross margin, 0% operating margin, and $0 in free cash flow (0% FCF margin).

Direct Sub-Reports: BHST RQD Cockpit BHST 12M Forecast BHST Earnings & Move BHST Dividends & DRIP BHST Insiders & 13F BHST Whale Options BHST Profit Sankey BHST News & Why